Arteriocyte a clinical stage Biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts, is developing proprietary stem cell and tissue engineering based therapies. Arteriocyte's goal is to develop commercially available stem cell based therapies using multiple sources of adult derived stem cells (marrow, peripheral cord blood, and cartilage) for disease where surgical interventions are inadequate.